World's Best Scientists 2026 revealed!

Overview

Elwyn Elias is affiliated with the University of Birmingham in the United Kingdom, focusing primarily on research within the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work encompasses multiple subfields including Hepatology, Epidemiology, Molecular Biology, Genetics, and Pathology and Forensic Medicine.

The scientist's research broadly covers key topics related to liver health, including Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, and Alcohol Consumption and Health Effects. Additional areas of focus include Tuberous Sclerosis Complex Research, the Complement system in diseases, Hepatitis C virus research, and RNA regulation and disease.

They have published work in several notable journals, with frequent appearances in the Journal of Investigative Dermatology, Journal of Clinical and Experimental Hepatology, Current Medical Issues, Indian Journal of Gastroenterology, and Nucleic Acids Research.

Recent papers authored or co-authored by Elwyn Elias include:

  • "An Update on the Management of Budd-Chiari Syndrome," 2020, Digestive Diseases and Sciences
  • "Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid," 2020, Thrombosis Research
  • "Low Volume Plasma Exchange and Low Dose Steroid Improve Survival in Patients With Alcohol-Related Acute on Chronic Liver Failure and Severe Alcoholic Hepatitis - Preliminary Experience," 2021, Journal of Clinical and Experimental Hepatology
  • "Improving Transplant-free Survival With Low-volume Plasma Exchange to Treat Children With Rodenticide Induced Hepatotoxicity," 2022, Journal of Clinical and Experimental Hepatology
  • "Low-volume plasma exchange and low-dose steroid to treat secondary hemophagocytic lymphohistiocytosis: A potential treatment for severe COVID-19?", 2020, Current Medical Issues

In terms of collaboration, Elwyn Elias has worked frequently with Uday Zachariah, Ashish Goel, C. E. Eapen, Vinoi George David, and Sukesh C. Nair, indicating a network of partnerships across research projects.

Best Publications

  • Budd–Chiari syndrome: a review by an expert panel

    Harry L.A Janssen;Juan-Carlos Garcia-Pagan;Elwyn Elias;Gilles Mentha

  • Etiology, Management, and Outcome of the Budd-Chiari Syndrome

    Sarwa Darwish Murad;Aurelie Plessier;Manuel Hernandez-Guerra;Federica Margherita Fabris

  • Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

    L Grellier;D Mutimer;M Ahmed;D Brown

  • Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking

    P.H. Dixon;N. Weerasekera;K.J. Linton;O. Donaldson

  • TIPS for Budd-Chiari Syndrome: Long-Term Results and Prognostics Factors in 124 Patients

    Juan Carlos Garcia–Pagán;Mathis Heydtmann;Sebastian Raffa;Aurélie Plessier

  • Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome

    Andrew Gough;Stephen Chapman;Kate Wagstaff;Paul Emery

  • Good long-term outcome of Budd-Chiari syndrome with a step-wise management

    Susana Seijo;Aurelie Plessier;Jildou Hoekstra;Alessandra Dell'Era

  • NEUROLOGICAL COMPLICATIONS FOLLOWING LIVER TRANSPLANTATION

    D.H. Adams;B. Gunson;L. Honigsberger;J. Buckels

  • Recurrence of autoimmune hepatitis after liver transplantation.

    Piotr Milkiewicz;Stefan G. Hubscher;Grzegorz Skiba;Mark Hathaway

  • Liver transplantation as a cure for acute intermittent porphyria.

    Zahir F. Soonawalla;Taner Orug;Michael Norman Badminton;George Hill Elder

  • Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis.

    A. E. A. Mahmoud;E. Elias;N. Beauchamp;J. T. Wilde

  • Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting

    N C Fisher;I McCafferty;M Dolapci;M Wali

  • High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation

    David Mutimer;Deenan Pillay;Elizabeth Dragon;Howard Tang

  • Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up.

    David Mutimer;Geoffrey Dusheiko;Catherine Barrett;Leonie Grellier

  • Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome

    C. E. Eapen;Dimitris Velissaris;Mathis Heydtmann;Bridget Gunson

  • Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient

    D Mutimer;D Pillay;P Shields;P Cane

  • Association of spinocerebellar disorders with cystic fibrosis or chronic childhood cholestasis and very low serum vitamin E.

    Elwyn Elias;D.P.R. Muller;J. Scott

  • Vanishing bile duct syndrome : a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma

    Stefan G. Hubscher;Matthew A. Lumley;Elwyn Elias

  • Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy

    Peter Dixon;N Weerasekera;K J Linton;O Donaldson

  • Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

    L Gruellier;D Mutimer;M Ahmed;D Brown

Frequent Co-Authors

Stefan G. Hubscher
Stefan G. Hubscher University of Birmingham
James Neuberger
James Neuberger Queen Elizabeth Hospital Birmingham
Roger Coleman
Roger Coleman University of Birmingham
Darius F. Mirza
Darius F. Mirza University of Birmingham
Paul M. Stewart
Paul M. Stewart University of Leeds
Dominique Valla
Dominique Valla Université Paris Cité
Juan Carlos García-Pagán
Juan Carlos García-Pagán University of Barcelona
Jonathan M. Rhodes
Jonathan M. Rhodes University of Liverpool
Robert A. Stockley
Robert A. Stockley University of Birmingham
Deenan Pillay
Deenan Pillay University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring alternatives in healthcare and medicine, numerous online programs offer flexibility and career advancement. Those with an associate's degree in nursing seeking to become nurse practitioners can consider specialized asn to np programs. These bridge programs help working nurses progress toward advanced practice roles without starting over.

Nutrition and wellness careers are also on the rise. Choosing a nutrition degrees online can be a practical way to enter this field, preparing you for both clinical and non-clinical positions in a growing job market.

If healthcare administration interests you, there are online mha programs accredited by CAHME that equip graduates with essential leadership and management skills for roles in hospitals, clinics, and health systems.

Registered nurses can also advance their education by enrolling in rn to bsn online without clinicals. These programs are ideal for nurses looking to expand their qualifications while balancing work and personal commitments.

Best Scientists Citing Elwyn Elias

Trending Scientists

Recently Published Articles